I am a board-certified general surgeon specializing in surgical oncology with a clinical expertise in melanoma and soft tissue sarcoma. I work closely with the patient and the comprehensive team of physicians to customize treatment plans for each individual.
In my research, I am investigating new ways to allow the immune system to fight cancer. I am also involved in clinical trials aimed at defining the role of current therapies and improving outcomes through novel new treatments. I am currently the principal investigator (PI) of a Phase II trial investigating the addition of systemic ipilimumab to isolated limb infusion for melanoma in transit disease. I am also the Memorial Sloan-Kettering PI of the multi-center MSLT-II trial. This trial randomizes patients with a positive sentinel lymph node to completon lymph node dissection versus ultrasound surveillance of the lymph nodes.